BidaskClub upgraded shares of Express Scripts (NASDAQ:ESRX) from a hold rating to a buy rating in a research note published on Thursday.

Other research analysts have also issued research reports about the company. Mizuho set a $67.00 price objective on Express Scripts and gave the company a hold rating in a report on Tuesday, October 24th. Robert W. Baird restated a hold rating and issued a $56.00 price objective on shares of Express Scripts in a report on Friday, September 1st. Royal Bank of Canada assumed coverage on Express Scripts in a report on Tuesday, September 19th. They issued a sector perform rating and a $68.00 price objective on the stock. ValuEngine downgraded Express Scripts from a buy rating to a hold rating in a research note on Friday, September 1st. Finally, Sanford C. Bernstein raised Express Scripts from an underperform rating to a market perform rating in a research note on Wednesday, December 6th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $73.77.

Shares of Express Scripts (NASDAQ:ESRX) traded up $0.45 during mid-day trading on Thursday, reaching $69.02. The company’s stock had a trading volume of 6,154,800 shares, compared to its average volume of 4,117,191. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market cap of $38,836.20, a price-to-earnings ratio of 10.02, a P/E/G ratio of 1.01 and a beta of 0.88. Express Scripts has a 12 month low of $55.80 and a 12 month high of $73.42.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.90. The company had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.74 EPS. equities research analysts predict that Express Scripts will post 7.01 earnings per share for the current year.

In related news, VP Phyllis S. Anderson sold 643 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now directly owns 98,628 shares in the company, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is currently owned by company insiders.

Several large investors have recently modified their holdings of ESRX. Parkside Financial Bank & Trust grew its position in Express Scripts by 0.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock valued at $551,000 after acquiring an additional 23 shares in the last quarter. CAPROCK Group Inc. grew its position in Express Scripts by 0.9% in the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock valued at $235,000 after acquiring an additional 33 shares in the last quarter. Sandy Spring Bank grew its position in Express Scripts by 0.6% in the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock valued at $413,000 after acquiring an additional 37 shares in the last quarter. Honkamp Krueger Financial Services Inc. grew its position in Express Scripts by 0.8% in the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock valued at $304,000 after acquiring an additional 38 shares in the last quarter. Finally, Buckingham Asset Management LLC grew its position in Express Scripts by 0.6% in the 2nd quarter. Buckingham Asset Management LLC now owns 8,874 shares of the company’s stock valued at $567,000 after acquiring an additional 52 shares in the last quarter. 88.44% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Express Scripts (ESRX) Upgraded to “Buy” at BidaskClub” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.watchlistnews.com/express-scripts-esrx-upgraded-to-buy-at-bidaskclub/1766395.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.